Concepedia

Mathew G. Angelos

MG

Statistics

Publications

11

Citations

627

H-Index

11

Active since

2009

Affiliations

University of Pennsylvania(Current)

Carisma Therapeutics (United States)

Hospital of the University of Pennsylvania

The University of Texas MD Anderson Cancer Center

UNC Lineberger Comprehensive Cancer Center

Mathew G. Angelos is an author at University of Pennsylvania specializing in life sciences, immunotherapy, and oncology.

Publications per year

2009–2025

11

Publications

11

CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial

Kim A. Reiss, Mathew G. Angelos, E. Claire Dees et al. · Nature Medicine · 2025 · 192 citations

Medicine, Molecular Medicine, Oncology +15

Characterization of Umbilical Cord Blood–Derived Late Outgrowth Endothelial Progenitor Cells Exposed to Laminar Shear Stress

Melissa A. Brown, Charles S. Wallace, Mathew G. Angelos et al. · Tissue Engineering Part A · 2009 · 78 citations · Full text

Engineering, Bioengineering, Cell Biology +12

Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells

Mathew G. Angelos, Paige N. Ruh, Beau R. Webber et al. · Blood · 2017 · 65 citations · Full text

Life Sciences, Developmental Biology, Pharmacology +11

EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models

Patrizia Porazzi, Siena Nason, Alberto Carturan et al. · Cancer Cell · 2025 · 49 citations

Life Sciences, Immunology, Oncology +11

A phase 1, first-in-human (FIH) study of the anti-HER2 CAR macrophage CT-0508 in subjects with HER2 overexpressing solid tumors.

Kim Anna Reiss, Yuan Yuan, Naoto T. Ueno et al. · Journal of Clinical Oncology · 2022 · 46 citations

Life Sciences, Immunology, Oncology +17

1–5 of 11